An ER-mitochondria tethering complex revealed by a synthetic biology screen - PubMed (original) (raw)

An ER-mitochondria tethering complex revealed by a synthetic biology screen

Benoît Kornmann et al. Science. 2009.

Abstract

Communication between organelles is an important feature of all eukaryotic cells. To uncover components involved in mitochondria/endoplasmic reticulum (ER) junctions, we screened for mutants that could be complemented by a synthetic protein designed to artificially tether the two organelles. We identified the Mmm1/Mdm10/Mdm12/Mdm34 complex as a molecular tether between ER and mitochondria. The tethering complex was composed of proteins resident of both ER and mitochondria. With the use of genome-wide mapping of genetic interactions, we showed that the components of the tethering complex were functionally connected to phospholipid biosynthesis and calcium-signaling genes. In mutant cells, phospholipid biosynthesis was impaired. The tethering complex localized to discrete foci, suggesting that discrete sites of close apposition between ER and mitochondria facilitate interorganelle calcium and phospholipid exchange.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

A synthetic biology screen to uncover mutants of the ER-mitochondria connection. (A) Rationale of the screen. (Top) In WT cells a yet unknown endogenous complex tethers the ER to the mitochondria. (Middle) Mutations causing the loss of the endogenous complex are detrimental and cause slow growth or cell death. (Bottom) Artificial ER-mitochondria tethering by ChiMERA can suppress the defects associated with the loss of the endogenous tether. (B) Outline of the ChiMERA. A central GFP molecule (green) is flanked by the mitochondria-directed N-terminal Tom70 presequence and transmembrane sequence (red) and the ER-directed C-terminal Ubc6 tail anchor sequence (blue). (C) Confocal Z-series across a yeast cell expressing the ChiMERA and a mitochondrial marker (mt-dsRed). ChiMERA displays a characteristic ER staining with additional thicker structures (arrowheads), which colocalize with mitochondria and represent sites of artificial tethering.

Fig. 2

Fig. 2

ChiMERA expression suppresses phenotypes associated with deletions of ERMES complex components. (A) 10-fold serial dilutions of a saturated culture were spotted on YP + ethanol/glycerol medium (YPEG) that supports growth by respiration or YP + dextrose (YPD) that allows fermentation. ChiMERA expression rescues growth of mdm12Δ, mdm34Δ, mdm10Δ, and mmm1Δ strains to different extents on respiration medium. (B) The mitochondrial shape defect of mdm12Δ and mdm34Δ strains is partially suppressed by expression of the ChiMERA. Cells bearing a mitochondria-targeted dsRed were imaged with the use of confocal fluorescence microscopy. Z projections across the whole volume of the cells are shown. A broken white line outlines the perimeter of the cell. ChiMERA expression has no effect in WT cells, other than formation of artificial tethering structures. mdm12Δ and mdm34Δ strains display rounded and enlarged mitochondria. The mitochondrial tubular shape is substantially restored upon ChiMERA expression. A quantitation of this effect is shown in fig. S4.

Fig. 3

Fig. 3

Mmm1 is an integral ER protein. (A) Disruption of a single ERMES component causes disassembly of the complex. Mmm1-GFP is localized in punctate structures in WT cells (a). Upon deletion of MDM12 (b), MDM34 (c), or MDM10 (d), Mmm1-GFP relocalizes to the ER. Mdm12-GFP displays a punctate pattern in WT cells (e). In the absence of Mmm1 (f), Mdm12-GFP displays a uniform mitochondrial localization (note the rounded swollen mitochondrial shape in mmm1Δ strains), but in the absence of MDM34 (g) or MDM10 (h), Mdm12-GFP relocalizes to the ER. Mdm34-GFP is also in punctate structures in WT cells (i). Upon mutation of any other complex member, Mdm34 relocalizes more uniformly to the mitochondrial membrane (j, k, l). Mdm10-GFP localizes to the whole surface of the mitochondria (m) and localizes to the rounded mitochondria after deletion of any other ERMES component (n, o, p). n.d., not determined. (B) Mmm1 is N-glycosylated. Whole-cell extract from a strain bearing a functional HA-tagged MMM1 gene was subjected to SDS–polyacrylamide gel electrophoresis with or without pretreatment with the glycosidase EndoHf. Detection was performed by Western blotting with an anti-HA antibody. The shift in electrophoretic mobility upon glycosidase treatment is indicative that Mmm1 is N-linked glycosylated. (C) Model of ERMES-mediated ER-mitochondria tethering. Mmm1 is an integral ER protein glycosylated on its N-terminal side. Mmm1 interacts with Mdm10, a OMM β-barrel protein. Mdm34 and Mdm12 promote this association, most probably via direct association.

Fig. 4

Fig. 4

Global analysis of ERMES genetic interactions. (A) Genetic interactions of MMM1 and MDM10 (top) and of MDM12 and MDM34 (bottom). Positive values indicate epistatic or suppressive interactions (i.e., double mutant grows better than expected from the combination of the phenotypes of each single mutant); negative values indicate a synthetic sick/lethal genetic interaction (i.e., double mutant grows worse than expected). (B) Histograms of correlation coefficients generated by comparing the profiles of genetic interaction for each ERMES component to all other 1493 profiles in the E-MAP analysis. ERMES components display strongest correlation to each other and to GEM1 and PSD1. (C) Thin-layer chromatography (TLC) analysis of steady-state total and mitochondrial phospholipids in WT and mdm12Δ strains. PA, phosphatidic acid; PI, phosphatidylinositol. (D) The aminoglycerophospholipid biosynthesis pathway is slowed down in ERMES mutants. Cultures of the indicated genotypes were labeled with 14C-serine, then chased with an excess cold serine. The variation of the PC/PS ratio was then measured over time by quantitative TLC, and its slope was estimated with linear regression. Error bars represent the SE of the linear regression.

Comment in

Similar articles

Cited by

References

    1. Voelker DR. J Lipid Res. 2003;44:441. - PubMed
    1. Achleitner G, et al. Eur J Biochem. 1999;264:545. - PubMed
    1. Vance JE. J Biol Chem. 1991;266:89. - PubMed
    1. Rizzuto R, Simpson AW, Brini M, Pozzan T. Nature. 1992;358:325. - PubMed
    1. Rizzuto R, Brini M, Murgia M, Pozzan T. Science. 1993;262:744. - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources